AZD5438

AZD5438

Biochem/physiol Actions

AZD5438 is an orally active, potent and reversible inhibitor against cyclin-dependent kinases (IC50 = 6 nM/Cyc E-CDK2, 14 nM/p25-CDK5, 16 nM/Cyc B1-CDK1, 20 nM/Cyc T-CDK9, 21 nM/Cyc D3-CDK6, 45 nM/Cyc A-CDK2, 449 nM/Cyc D1-CDK4, 821 nM/Cyc H-CDK7; [ATP] = Km) and glycogen synthase kinase GSK-3β≤ (IC50 = 17 nM) without significant inhibitory potency toward 30 other kinases (≤75% inhibition at 10 µM). AZD5438 effectively inhibits cellular CDK substrates phosphorylation and displays antiproliferation activity against a broad spectrum of human cancer cultures (IC50 from 0.2 µM/MCF to 1.7 µM/ARH-77) by inducing cell cycle arrest at G2-M, S, and G1. Oral administration (50 mg/kg/12 h or 75 mg/kg/day) is efficacious against human tumor xenograft growth in mice in vivo.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Storage Temp. Solubility Form Assay Price
3575462 AZD5438 yellow to orange 100 SIGMA-ALDRICH 2-8°C DMSO: 20 mg/mL, clear powder ≥97% (HPLC)
You need to be logged in to see prices.
3575463 AZD5438 yellow to orange 100 SIGMA-ALDRICH 2-8°C DMSO: 20 mg/mL, clear powder ≥97% (HPLC)
You need to be logged in to see prices.
You need to be logged in to see prices.